1008119-70-7

Basic information

• Product Name: 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97%
• Synonyms: 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97%;3-fluoro-4-(Morpholine-4-carbonyl)phenylboronic acid
• CAS NO: 1008119-70-7
• Molecular Formula: C₁₁H₁₃BFNO₄
• Molecular Weight: 253.0346232
• Mol File: 1008119-70-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97%(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97%(1008119-70-7)
• EPA Substance Registry System: 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97%(1008119-70-7)

Safety Data

• Hazardous Substances Data: 1008119-70-7(Hazardous Substances Data)

Usage

General Description

3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97% is a boronic acid compound that is predominantly composed of 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, with a purity of 97%. It has multiple applications in organic synthesis and the pharmaceutical industry due to its ability to form stable complexes with various organic molecules. 3-Fluoro-4-(4-Morpholinylcarbonyl)benzeneboronic acid, 97% is also used in the development of novel drugs and as a building block in the synthesis of complex organic compounds. Additionally, it has potential use in the production of materials for various biomedical applications.

Upstream product

• 110-91-8 morpholine 
• 120153-08-4 4-(dihydroxyboranyl)-2-fluorobenzoic acid 

Downstream Products

• 1617498-95-9 5-[4-fluoro-3-(morpholinomethyl)phenyl]-3-(1-isopropyltriazol-4-yl)pyridin-2-amine 
• 1617498-92-6 (4-(6-amino-5-(1-isopropyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-2-fluorophenyl)(morpholino)methanone 
• 1617499-20-3 (5-(6-amino-5-(1-isopropyl-1H-1,2,3-triazol-4-yl)pyridin-3-yl)-2-fluorophenyl)(morpholino)methanone 

Relevant articles and documents

Improving the pharmacokinetic and CYP inhibition profiles of azaxanthene-based glucocorticoid receptor modulators-identification of (S)-5-(2-(9-fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5 H -chromeno[2,3- b ]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydr

An empirical approach to improve the microsomal stability and CYP inhibition profile of lead compounds 1a and 1b led to the identification of 5 (BMS-341) as a dissociated glucocorticoid receptor modulator. Compound 5 showed significant improvements in pha

FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-KB ACTIVITY AND USE THEREOF

Novel non-steroidal compounds are provided which are useful in treating diseases or disorders associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity, including metabolic and inflammatory and immune diseases or disorders, ha